{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15582419", "DateCompleted": {"Year": "2005", "Month": "05", "Day": "02"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0960-894X", "JournalIssue": {"Volume": "15", "Issue": "1", "PubDate": {"Year": "2005", "Month": "Jan", "Day": "03"}}, "Title": "Bioorganic & medicinal chemistry letters", "ISOAbbreviation": "Bioorg Med Chem Lett"}, "ArticleTitle": "Amide derivatives of 9,11-seco-estra-1,3,5(10)-trien-11-oic acid as modified orally active estrogen agonists with moderate antagonistic activity.", "Pagination": {"StartPage": "99", "EndPage": "102", "MedlinePgn": "99-102"}, "Abstract": {"AbstractText": ["Synthesis of amide derivatives of 9,11-seco-estra-1,3,5(10)-trien-11-oic acid containing alkyl and aromatic amine residues has been carried out with an aim to prepare orally active estrogen antagonists. Modification of the estradiol molecule in the form of C-seco-amide derivatives has led to their high oral absorption. Compounds 7 an n-propyl amide, 8 an n-butyl amide, and 16 a p-anisidyl amide of C-seco-estrane showed significant estrogen antagonistic activity (>20%), while, the majority of compounds possessed high estrogen agonistic activity on oral administration at 10mg/kg dose in rats."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Phytochemistry Division, Central Institute of Medicinal and Aromatic Plants, PO CIMAP, Kukrail Road, Lucknow 226015, India."}], "Identifier": [], "LastName": "Negi", "ForeName": "Arvind Singh", "Initials": "AS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chaturvedi", "ForeName": "Devdutt", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gupta", "ForeName": "Atul", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ray", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dwivedy", "ForeName": "Anila", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Singh", "ForeName": "M M", "Initials": "MM"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Bioorg Med Chem Lett", "NlmUniqueID": "9107377", "ISSNLinking": "0960-894X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "9,11-seco-estra-1,3,5(10)-trien-11-oic acid"}, {"RegistryNumber": "0", "NameOfSubstance": "Amides"}, {"RegistryNumber": "0", "NameOfSubstance": "Estrogen Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Estrogens"}, {"RegistryNumber": "2DI9HA706A", "NameOfSubstance": "Estrone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": ["chemistry"], "DescriptorName": "Amides"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Estrogen Antagonists"}, {"QualifierName": ["agonists", "chemistry"], "DescriptorName": "Estrogens"}, {"QualifierName": ["administration & dosage", "analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Estrone"}, {"QualifierName": [], "DescriptorName": "Rats"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "7", "Day": "25"}, {"Year": "2004", "Month": "10", "Day": "9"}, {"Year": "2004", "Month": "12", "Day": "8", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "5", "Day": "3", "Hour": "9", "Minute": "0"}, {"Year": "2004", "Month": "12", "Day": "8", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15582419", "10.1016/j.bmcl.2004.10.031", "S0960-894X(04)01259-4"]}}], "PubmedBookArticle": []}